I-Cabozantinib Malate CAS 1140909-48-3 yeFactory engabizi kakhulu kwi-Anti-Tumor
Inkcazo emfutshane:
Umhlaza womlomo wesibeleko, okwaziwa ngokuba ngumhlaza womlomo wesibeleko, yeyona thumba ixhaphakileyo kwi-gynecological tract kumalungu okuzala kwabasetyhini. I-HPV yeyona nto ibalulekileyo ebangela esi sifo. Umhlaza womlomo wesibeleko unokuthintelwa ngokuhlolwa rhoqo kunye nokugonywa. Umhlaza womlomo wesibeleko kwangethuba uyanyangeka kakhulu kwaye i-prognosis ilungile.
"Ubuhle buza kuqala; inkonzo yeyona nto iphambili; amashishini amancinci yintsebenziswano" yifilosofi yethu yenkampani elandelwa rhoqo kwaye ilandelwa yinkampani yethu yeCabozantinib Malate CAS 1140909-48-3 ye-Anti-Tumor, Ngenxa yokusebenza kwethu nzima, besisoloko siphambili ekuveliseni izinto ezintsha zobuchwepheshe obucocekileyo. Sibe liqabane elinobuhlobo nokusingqongileyo onokulithemba. Nxibelelana nathi namhlanje ukuze ufumane ulwazi olongezelelweyo!
"Ukugqwesa kuza kuqala; inkonzo yeyona nto iphambili; amashishini amancinci yintsebenziswano" yifilosofi yethu yombutho ejongwa rhoqo kwaye ilandelwa yinkampani yethu ukuzeUmthengisi weCabozantinib Malate waseTshayina iCAS 1140909-48-3 kunye neCabozantinib Malate CAS 1140909-48-3, ngoku sinamava eminyaka esi-8 kwimveliso kunye namava eminyaka emi-5 ekurhwebeni nabathengi kwihlabathi liphela. Abathengi bethu basasazwa kakhulu eMntla Melika, eAfrika naseMpuma Yurophu. Singabonelela ngeemveliso ezisemgangathweni ophezulu ngexabiso elikhuphisanayo.
I-Epidemiology
I-WHO ikhuphe ingxelo ngo-2018 ukuba inani labantu abanesifo somhlaza womlomo wesibeleko kwihlabathi liphela limalunga ne-13 kubantu abayi-100000 eWei minyaka le, kwaye izinga lokufa limalunga ne-7 kubantu abayi-100000 abasweleke ngenxa yomhlaza womlomo wesibeleko. Ngo-2018, bekukho malunga ne-569000 yamatyala amatsha omhlaza womlomo wesibeleko kunye nokufa okungu-311000, apho ama-84% awo enzeka kumazwe angaphantsi kophuhliso lwezorhwebo.
Ukugula nokufa kwabantu ababulawa ngumhlaza womlomo wesibeleko kwihlabathi liphela kuye kwehla kakhulu kwiminyaka engama-40 edlulileyo, nto leyo enxulumene nokuqina kwemfundo yezempilo, ugonyo lwe-HPV kunye nokuhlolwa komhlaza womlomo wesibeleko.
Esi sifo sixhaphake kakhulu kubasetyhini abakwiminyaka ephakathi (35-55). Ama-20% amatyala ayenzeka kubantu abaneminyaka engaphezu kwama-65 ubudala kwaye anqabile kulutsha.
Iindlela zokuxilonga umhlaza womlomo wesibeleko:
1. Uvavanyo lwe-cytological lwe-curettage yomlomo wesibeleko.
Le ndlela inokubhaqa izilonda zomlomo wesibeleko ngaphambi komhlaza kunye nomhlaza womlomo wesibeleko kwangethuba, kuba kukho izinga elingalunganga le-5% mi 10%, ngoko ke izigulana kufuneka zihlolwe rhoqo.
2. Uvavanyo lwe-ayodini.
I-epithelium ye-squamous yomlomo wesibeleko kunye ne-vaginal epithelium ityebile kwi-glycogen kwaye inokudaywa ngombala omdaka ngesisombululo se-iodine, ngelixa ukukhukuliseka komlomo wesibeleko kunye ne-epithelium ye-squamous engaqhelekanga (kuquka i-hyperplasia engaqhelekanga, i-carcinoma in situ kunye ne-carcinoma ehlaselayo) azikho kwaye aziyi kudaywa.
3. Uvavanyo lwebhayoloji yomlomo wesibeleko kunye nomjelo womlomo wesibeleko.
Ukuba i-cervical smear cytology ikwi-grade Ⅲ ~ Ⅳ, kodwa i-cervical biopsy i-negative, kufuneka kuthathwe izicubu ezininzi ukuze kuhlolwe i-pathological.
4. I-ColposcopyIntle kakhulu iza kuqala; inkonzo yeyona nto iphambili; amashishini amancinci yintsebenziswano” yifilosofi yethu yenkampani ejongwa rhoqo kwaye ilandelwa yinkampani yethu yeCabozantinib Malate CAS 1140909-48-3 ye-Anti-Tumor, Ngenxa yokusebenza kwethu nzima, besisoloko siphambili ekuveliseni izinto ezintsha zobuchwepheshe obucocekileyo. Sibe liqabane elinobuhlobo nokusingqongileyo onokulithemba. Nxibelelana nathi namhlanje ukuze ufumane ulwazi olongezelelweyo!
Eyona Fektri Ixabiso EliphantsiUmthengisi weCabozantinib Malate waseTshayina iCAS 1140909-48-3 kunye neCabozantinib Malate CAS 1140909-48-3, ngoku sinamava eminyaka esi-8 kwimveliso kunye namava eminyaka emi-5 ekurhwebeni nabathengi kwihlabathi liphela. Abathengi bethu basasazwa kakhulu eMntla Melika, eAfrika naseMpuma Yurophu. Singabonelela ngeemveliso ezisemgangathweni ophezulu ngexabiso elikhuphisanayo.
